Logo - International Journal of Pharmaceutical Compounding

Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1)

Author(s):  Allen Loyd V Jr

Issue:  Nov/Dec 2019 - Volume 23, Number 6
View All Articles in Issue

Abstract:  A formulation for preparing Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1). Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, tadalafil, formulation, erectile dysfunction, benign prostatic hyperplasia, pulmonary arterial hypertension, female sexual dysfunction, phosphodiesterase type 5, PDE5 inhibitor, cyclic guanosine monophosphate, CMP

Related Categories: EXCIPIENTS, FORMULATIONS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, UROLOGY/URINARY TRACT

Purchase this article for download in electronic PDF format from IJPC at for $35 at:
http://www.ijpc.com/Products/ProductAddToCart.cfm?PID=4695

Search the entire IJPC archive by keyword, topic, or issue at:
http://ijpc.com/Products